Functional significance of a C–>A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

Sachse, Christoph, Brockmöller, Jürgen, Bauer, Steffen, Roots, Ivar·1999·British Journal of Clinical Pharmacology
DOI 10.1046/j.1365-2125.1999.00898.x

Cited by (749)

Items 301–400 of 749

  1. Caffeine, selected metabolic gene variants, and risk for neural tube defects
    Rebecca J. Schmidt, Paul A. Romitti, Trudy L. Burns, Jeffrey Clark Murray, Marilyn L. Browne, Charlotte M. Druschel, Richard S. Olney · 2010 · Birth Defects Research Part A Clinical and Molecular Teratology
  2. The Effect of Caffeine on Performance in Collegiate Tennis Players
    Courtney S. Klein, Adam J. Clawson, Michael Martin, Michael John Saunders, Judith A. Flohr, Marta K. Bechtel, Wade Dunham, Melyssa Hancock, Christopher J. Womack · 2012 · Journal of Caffeine Research
  3. The effect of CYP1A2 gene polymorphisms on Theophylline metabolism and chronic obstructive pulmonary disease in Turkish patients
    Ahmet Uslu, Candan Öğüş, Tülay Özdemir, Türker Bilgen, Özgür Tosun, İbrahim Keser · 2010 · BMB Reports
  4. Genetic determinants of cognitive responses to caffeine drinking identified from a double-blind, randomized, controlled trial
    Giulia Renda, Giorgia Committeri, Marco Zimarino, Marta Di Nicola, Alfonso Tatasciore, Benedetta Ruggieri, Ettore Ambrosini, Vanda Viola, Ivana Antonucci, Liborio Stuppia et al. · 2015 · European Neuropsychopharmacology
  5. Synergism between Oral Estrogen Therapy and Cytochrome P450 3A5*1 Allele on the Risk of Venous Thromboembolism among Postmenopausal Women
    Marianne Canonico, Élodie Bouaziz-Amar, Laure Carcaillon‐Bentata, Céline Verstuyft, Anne Guiochon‐Mantel, Laurent Becquemont, Pierre‐Yves Scarabin · 2008 · The Journal of Clinical Endocrinology & Metabolism
  6. Risk of Testicular Germ Cell Cancer in Relation to Variation in Maternal and Offspring CytochromeP450 Genes Involved in Catechol Estrogen Metabolism
    Jacqueline Rose Starr, Chu Chen, David R. Doody, Li Hsu, Sherianne Ricks, Noel S. Weiss, Stephen M. Schwartz · 2005 · Cancer Epidemiology Biomarkers & Prevention
  7. Case-only study of interactions between metabolic enzymes and smoking in colorectal cancer
    Chunhong Fan, Mingjuan Jin, Kun Chen, Yongjing Zhang, Shuang‐Shuang Zhang, Bing Liu · 2007 · BMC Cancer
  8. Genetic Polymorphisms of Cytochrome P450 and Matrix Metalloproteinase in Chronic Obstructive Pulmonary Disease
    Shih-Lung Cheng, Chong‐Jen Yu, Pan‐Chyr Yang · 2009 · Biochemical Genetics
  9. CYP1A2 Genetic Polymorphisms are Associated with Early Antidepressant Escitalopram Metabolism and Adverse Reactions
    Hsiang‐Wei Kuo, Shu Chih Liu, Hsiao‐Hui Tsou, Sheng-Wen Liu, Keh-Ming Lin, Shao‐Chun Lu, Mei‐Chun Hsiao, Chin‐Fu Hsiao, Chia-Yih Liu, Chia-Hui Chen et al. · 2013 · Pharmacogenomics
  10. ADME pharmacogenetics: current practices and future outlook
    Iris Grossman · 2009 · Expert Opinion on Drug Metabolism & Toxicology
  11. Polymorphisms in phase I and phase II metabolism genes and risk of chronic benzene poisoning in a Chinese occupational population
    Pin Sun, Ji Qian, Zhongbin Zhang, Junxiang Wan, Fen Wu, Xipeng Jin, Wei-wei Fan, Jin Li, Naiqing Zhao, David C. Christiani et al. · 2008 · Carcinogenesis
  12. Role of CYP1A2 polymorphisms on lung cancer risk in a prospective study
    Sofia Pavanello, Ugo Fedeli, Giuseppe Mastrangelo, Federica Rota, Kim Overvad, Ole Raaschou‐Nielsen, Anne Marie Tjønneland, Ulla Birgitte Vogel · 2012 · Cancer Genetics
  13. FUNCTIONAL ANALYSIS OF THREE CYP1A2 VARIANTS FOUND IN A JAPANESE POPULATION
    Yoshiro Saito, Nobumitsu Hanioka, Keiko Maekawa, Takashi Isobe, Yumi Tsuneto, Ryosuke Nakamura, Akiko Soyama, Shogo Ozawa, Toshiko Tanaka-Kagawa, Hideto Jinno et al. · 2005 · Drug Metabolism and Disposition
  14. A nicotineC-oxidase gene (CYP2A6) polymorphism important for promoter activity
    Marià Pitarque, Oliver von Richter, Cristina Rodríguez‐Antona, Jue Wang, Mikael Oscarson, Magnus Ingelman‐Sundberg · 2004 · Human Mutation
  15. Identification of novel polymorphisms in the 5’ flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance
    Katherine Jean Aitchison, Frank J. Gonzalez, Linda C. Quattrochi, Andrea Sapone, Jing Hua Zhao, Hani Zaher, Guillermo Elizondo, C. Bryant, Janet Munro, David Andrew Collier et al. · 2000 · Pharmacogenetics
  16. Paraxanthine Supplementation Increases Muscle Mass, Strength, and Endurance in Mice
    Ralf Jäger, Martin Purpura, Shawn D. Wells, Kylin Liao, Ashok Godavarthi · 2022 · Nutrients
  17. Melatonin in Children with Autism Spectrum Disorders: How Does the Evidence Fit Together?
    Olivia J. Veatch, Suzanne E. Goldman, Karen W. Adkins, Beth Ann Malow · 2015 · PubMed
  18. Genetic Polymorphisms Affecting Drug Metabolism
    Ann K. Daly · 2012 · Advances in pharmacology
  19. Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
    Mishal Qubad, Robert A. Bittner · 2023 · Therapeutic Advances in Psychopharmacology
  20. Genetic polymorphism of cytochrome P450s and P‐glycoprotein in the Finnish population
    Johanna Hilli, Anders Rane, Stefan Lundgren, Leif Bertilsson, Kari Laine · 2007 · Fundamental and Clinical Pharmacology
  21. Effect of Caffeine Intake 12 or 24 Hours Prior to Melatonin Intake and CYP1A2*1F Polymorphism on CYP1A2 Phenotyping by Melatonin
    Sebastian Härtter, Tuomas Korhonen, Stefan Lundgren, Anders Rane, Ari Tolonen, Miia Turpeinen, Kari Laine · 2006 · Basic & Clinical Pharmacology & Toxicology
  22. Genetic polymorphism in bladder cancer
    Xifeng Wu · 2006 · Frontiers in bioscience
  23. Stillbirth and slow metabolizers of caffeine: comparison by genotypes
    Bodil Hammer Bech, Herman Nybro Autrup, Ellen Aagaard Nohr, Tine Brink Henriksen, Jørn Olsen · 2006 · International Journal of Epidemiology
  24. Pharmacogenetic assessment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2 genes
    Vural Özdemir, Vincenzo Santo Basile, Mario Masellis, James L. Kennedy · 2001 · Journal of Biochemical and Biophysical Methods
  25. The pharmacogenetics of treatment with olanzapine
    Pablo Zubiaur, Paula Soria‐Chacartegui, Gonzalo Villapalos‐García, Juan J Gordillo-Perdomo, Francisco Abad‐Santos · 2021 · Pharmacogenomics
  26. Current status on genome–metabolome-wide associations: an opportunity in nutrition research
    Ivan Montoliu, Ulrich K. Genick, Mirko Ledda, Sebastiano Collino, François‐Pierre Martin, Johannes le Coutre, Serge Rezzi · 2012 · Genes & Nutrition
  27. Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine
    Giovanna Gentile, Serena Missori, Marina Borro, Alisa Sebastianelli, Maurizio Simmaco, Paolo Martelletti · 2010 · The Journal of Headache and Pain
  28. Influence of cytochrome P450 oxidoreductase genetic polymorphisms on CYP1A2 activity and inducibility by smoking
    Maria Dobrinas, Jacques Cornuz, Leticia Pedrido, Chin B. Eap · 2012 · Pharmacogenetics and Genomics
  29. Identification and Functional Characterization of a Conserved, Nuclear Factor 1-like Element in the Proximal Promoter Region ofCYP1A2 Gene Specifically Expressed in the Liver and Olfactory Mucosa
    Jianhua Zhang, Qing-Yu Zhang, Jiancheng Guo, Yali Zhou, Xinxin Ding · 2000 · Journal of Biological Chemistry
  30. Pharmacogenomics can improve antipsychotic treatment in schizophrenia
    Qingqing Xu, Xi Lawrence Wu, Yuyu Xiong, Qinghe Xing, Lin He, Shengying Qin · 2013 · Frontiers of Medicine
  31. Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis
    Wen-Xia Sun, Yinghua Chen, Zhizhong Liu, Jian‐Jun Xie, Wei Wang, Ya-Ping Du, Yu Chen, Xuliang Shen, Xiao‐Feng He, Lixia Wu et al. · 2014 · Molecular Genetics and Genomics
  32. Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers
    Joshua E. Muscat, Brian P. Pittman, Wayne A. Kleinman, Philip J. Lazarus, Steven D. Stellman, John P. Richie · 2008 · Biochemical Pharmacology
  33. The significance of sampling time in therapeutic drug monitoring of clozapine
    Michelle Iris Jakobsen, Julie Rask Larsen, Camilla Kara Svensson, Sys Stybe Johansen, Kristían Línnet, Jimmi Nielsen, Anders Fink‐Jensen · 2016 · Acta Psychiatrica Scandinavica
  34. Coffee consumption and risk of myocardial infarction: a dose-response meta-analysis of observational studies
    Long Mo, Wei Xie, Xiao-qun Pu, Dongsheng Ouyang · 2018 · Oncotarget
  35. Current therapeutic targets and multifaceted physiological impacts of caffeine
    Xinjie Song, Nikhil Kirtipal, Sunjae Lee, Petr Malý, Shiv Bharadwaj · 2023 · Phytotherapy Research
  36. RETRACTED: Role of CYP1A2*1F polymorphism in cancer risk: Evidence from a meta-analysis of 46 case–control studies
    Zhong Tian, Yiling Li, Lin Zhao, Chen-Liang Zhang · 2013 · Gene · Retracted
  37. Interaction of cigarette smoking and carcinogen-metabolizing polymorphisms in the risk of colorectal polyps
    Zhenming Fu, Martha J. Shrubsole, Guoliang Li, Walter E. Smalley, David W. Hein, Qiuyin Cai, Reid M. Ness, Wei Zheng · 2013 · Carcinogenesis
  38. Functional polymorphisms of the cytochrome P450 1A2 (CYP1A2) gene and prolonged QTc interval in schizophrenia
    Joshua K. Tay, Chay Hoon Tan, Siow‐Ann Chong, Ene‐Choo Tan · 2007 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  39. Review: Influence of the CYP450 Genetic Variation on the Treatment of Psychotic Disorders
    Lorena Carrascal-Laso, María Isidoro‐García, Ignacio Ramos-Gallego, Manuel Franco · 2021 · Journal of Clinical Medicine
  40. Genetic susceptibility to teratogens: State of the art
    Matteo Cassina, Leonardo Salviati, Elena Di Gianantonio, Maurizio Clementi · 2012 · Reproductive Toxicology
  41. Metabolic differences between Asian and Caucasian patients on clozapine treatment
    Mythily Subramaniam, Chee H. Ng, Siow‐Ann Chong, Rathi Mahendran, Tim J R Lambert, Elaine Pek, Chan Yiong Huak · 2007 · Human Psychopharmacology Clinical and Experimental
  42. Synthesis of a selective ratiometric fluorescent probe based on Naphthalimide and its application in human cytochrome P450 1A
    Xiuxuan Zhang, Yan Zhou, Xiaofei Gu, Yu Cheng, Man‐Xin Hong, Liqiang Yan, Fulong Ma, Zhengjian Qi · 2018 · Talanta
  43. Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan
    Masahide Koda, Motoki Iwasaki, Yuko Yamano, Xi Lu, Takahiko Katoh · 2017 · Environmental Health and Preventive Medicine
  44. Exposure levels and cytochrome P450 1A2 activity, but not N-acetyltransferase, glutathione S-transferase (GST) M1 and T1, influence urinary mutagen excretion in smokers.
    Sofia Pavanello, Paola Simioli, Silvia Lupi, Pasquale Gregorio, Erminio Clonfero · 2002 · PubMed
  45. Genetic association analysis of functional polymorphisms in the cytochrome P450 1A2 (CYP1A2) gene with tardive dyskinesia in Japanese patients with schizophrenia
    Chima Matsumoto, Osamu Ohmori, Takahiro Shinkai, Hiroko Hori, Jun Nakamura · 2004 · Psychiatric Genetics
  46. Correction to: The Effect of Acute Caffeine Ingestion on Endurance Performance: A Systematic Review and Meta-Analysis
    Kyle Southward, Kay Janice Rutherfurd-Markwick, Ajmol Ali · 2018 · Sports Medicine
  47. ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease
    Siokas, Vasileios, Aloizou, Athina-Maria, Tsouris, Zisis, Liampas, Ioannis, Liakos, Panagiotis, Calina, Daniela, Docea, Anca Oana, Tsatsakis, Aristidis, Bogdanos, Dimitrios P., Hadjigeorgiou, Georgios M. et al. · 2021 · Journal of Clinical Medicine
  48. Pharmacokinetics and Pharmacogenetics of Carbamazepine in Children
    Nataša Djordjević, Slobodan Јаnkovic, Jasmina R. Milovanovic · 2017 · European Journal of Drug Metabolism and Pharmacokinetics
  49. Inhibition of Baicalin on Metabolism of Phenacetin, a Probe of CYP1A2, in Human Liver Microsomes and in Rats
    Na Gao, Bing Qi, Fang-jun Liu, Yan Fang, Jun Zhou, Lin-Jing Jia, Hai–Ling Qiao · 2014 · PLoS ONE
  50. Genetic polymorphisms of cytochrome P450 in patients with hepatitis C virus‐associated hepatocellular carcinoma
    JUNKO MOCHIZUKI, Shigeto MURAKAMI, Akira Sanjo, Ichiro Takagi, Setsuko Akizuki, Akihiro Ohnishi · 2005 · Journal of Gastroenterology and Hepatology
  51. Coffee Intake
    Marilyn C. Cornelis · 2012 · Progress in molecular biology and translational science
  52. Caffeine N3-demethylation (CYP1A2) in a population with an increased exposure to polychlorinated biphenyls
    Maria Skaalum Petersen, Jónrit Halling, Per Damkier, Flemming Nielsen, Philippe Grandjean, Pál Weihe, Kim Brøsen · 2006 · European Journal of Clinical Pharmacology
  53. Pairwise Combinations of Estrogen Metabolism Genotypes in Postmenopausal Breast Cancer Etiology
    Timothy Richard Rebbeck, Andrea B. Troxel, Amy H. Walker, Saarene Panossian, Stephen Gallagher, Ekaterina G. Shatalova, Rebecca L. Blanchard, Sandra A. Norman, Greta R. Bunin, Angela M. DeMichele et al. · 2007 · Cancer Epidemiology Biomarkers & Prevention
  54. Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing
    Carsten Skarke, Anja Kirchhof, Gerd Geißlinger, Jörn Lötsch · 2005 · European Journal of Clinical Pharmacology
  55. Influence of CYP1A1/CYP1A2 and AHR polymorphisms on systemic olanzapine exposure
    Mao Mao Söderberg, Tore Haslemo, Espen Molden, Marja­‐Liisa Dahl · 2013 · Pharmacogenetics and Genomics
  56. Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes
    Anja Rudolph, Juan Sáinz, Rebecca Hein, Michael Hoffmeister, Bernd Frank, Asta Försti, Hermann Brenner, Kari Hemminki, Jenny C. Chang-Claude · 2011 · Endocrine Related Cancer
  57. Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing
    Sam Mostafa, Thomas M. Polasek, Chad Bousman, Daniel J. Müller, Leslie J. Sheffield, Joel Rembach, Carl M. J. Kirkpatrick · 2022 · Pharmacogenomics
  58. The CYP1A2 –163C>A polymorphism is associated with clozapine-induced generalized tonic-clonic seizures in Brazilian schizophrenia patients
    Fabiana B. Kohlrausch, Clarissa Severino Gama, Maria Inês Rodrigues Lobato, Paulo Silva Belmonte-de-Abreu, Ángel Carracedo, Mara Helena Hutz · 2013 · Psychiatry Research
  59. Determination of ?3858G?A and ?164C?A genetic polymorphisms of CYP1A2 in blood and saliva by rapid allelic discrimination: large difference in the prevalence of the ?3858G?A mutation between Caucasians and Asians
    Liliane Todesco, Michael T�r�k, Stephan Kr henb hl, Markus Wenk · 2003 · European Journal of Clinical Pharmacology
  60. Human prostate epithelial cells metabolize chemicals of dietary origin to mutagens
    Terence A. Lawson, Carol Kolar · 2002 · Cancer Letters
  61. Caffeine Use among Active Duty Navy and Marine Corps Personnel
    Joseph J. Knapik, Daniel W. Trone, Susan M. McGraw, Ryan A. Steelman, Krista Gail Austin, Harris R. Lieberman · 2016 · Nutrients
  62. Quantile-Specific Heritability may Account for Gene–Environment Interactions Involving Coffee Consumption
    Paul T. Williams · 2020 · Behavior Genetics
  63. Screening of 214 Single Nucleotide Polymorphisms in 44 Candidate Cancer Susceptibility Genes: A Case–Control Study on Gastric and Colorectal Cancers in the Japanese Population
    Shinobu Ikeda, Shizuka Sasazuki, Syusuke Natsukawa, Kozo Shaura, Yoichi Koizumi, Yoshio Kasuga, Sumiko Ohnami, Hiromi Sakamoto, Teruhiko Yoshida, Motoki Iwasaki et al. · 2008 · The American Journal of Gastroenterology
  64. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival
    Jirong Long, Qiuyin Cai, Xiao‐Ou Shu, Hui Cai, Yu‐Tang Gao, Wei Zheng · 2007 · Pharmacogenetics and Genomics
  65. Caffeine metabolism rate influences coffee perception, preferences and intake
    Camilla Masi, Caterina Dinnella, Nicola Pirastu, John Prescott, Erminio Monteleone · 2016 · Food Quality and Preference
  66. The Effect of the CYP1A2 −163 C > A Polymorphism on Caffeine Metabolism and Subsequent Cycling Performance
    Gabrielle E. W. Giersch, James C. Boyett, Trent A. Hargens, Nicholas D. Luden, Michael John Saunders, Hannah Daley, Christine A. Hughey, Ahmed El‐Sohemy, Christopher J. Womack · 2018 · Journal of Caffeine and Adenosine Research
  67. Caffeine, CYP1A2 Genotype, and Exercise Performance: A Systematic Review and Meta-Analysis
    BARRETO, GABRIEL, ESTEVES, GABRIEL P., MARTICORENA, FELIPE, OLIVEIRA, TAMIRES N., GRGIC, JOZO, SAUNDERS, BRYAN · 2024 · Medicine & Science in Sports & Exercise
  68. Sex Related Differences in the Complex Relationship between Coffee, Caffeine and Atrial Fibrillation
    Francesca Coppi, Valentina Bucciarelli, Giorgia Sinigaglia, Giada Zanini, Valentina Selleri, Milena Nasi, Marcello Pinti, Sabina Gallina, Anna Vittoria Mattioli · 2023 · Nutrients
  69. CYP1A1/2 Haplotypes and Lung Cancer and Assessment of Confounding by Population Stratification
    Melinda C. Aldrich, Steve Selvin, Helen M. Hansen, Lisa F. Barcellos, Margaret Wrensch, Jennette D. Sison, Karl T. Kelsey, Patricia A. Buffler, Charles P. Quesenberry, Michael F. Seldin et al. · 2009 · Cancer Research
  70. Breast density and polymorphisms in genes coding for CYP1A2 and COMT: the Multiethnic Cohort
    Yumie Takata, Gertraud Maskarinec, Loı̈c Le Marchand · 2007 · BMC Cancer
  71. Consumption of Charcoal‐Broiled Meat as an Experimental Tool for Discerning CYP1A2‐Mediated Drug Metabolism in vivo
    John Teilmann Larsen, Kim Brøsen · 2005 · Basic & Clinical Pharmacology & Toxicology
  72. Ah receptor, CYP1A1, CYP1A2 and CYP1B1 gene polymorphisms are not involved in the risk of recurrent pregnancy loss
    Yasuaki Saijo, Fumihiro Sata, Hideto Yamada, K. Suzuki, S. Sasaki, Toshikazu Kondo, Yingyan Gong, Emi Hirayama Kato, Shigeki Shimada, Mamoru Morikawa et al. · 2004 · Molecular Human Reproduction
  73. Role of metabolic polymorphisms NAT2 and CYP1A2 on urinary mutagenicity after a pan-fried hamburger meal
    Sofia Pavanello, Paola Simioli, Giuseppe Mastrangelo, Silvia Lupi, Gigliola Gabbani, Pasquale Gregorio, Erminio Clonfero · 2002 · Food and Chemical Toxicology
  74. Combined effects of AHR, CYP1A1, and XRCC1 genotypes and prenatal maternal smoking on infant birth size: Biomarker assessment in the Hokkaido Study
    Sumitaka Kobayashi, Fumihiro Sata, Seiko Sasaki, Titilola Serifat Braimoh, Atsuko Araki, Chihiro Miyashita, Houman Goudarzi, Sachiko Kobayashi, Reiko Kishi · 2016 · Reproductive Toxicology
  75. Low CYP1A2 activity associated with testicular cancer
    Kirsten Kjeldgaard Vistisen · 2004 · Carcinogenesis
  76. CYP1A2*1F Polymorphism Decreases Clinical Response to Clozapine in Patients with Schizophrenia
    Hakan Balıbey, Cengiz Başoğlu, Stefan Lundgren, Melih Onder Babaoglu, Ümit Yaşar, Hasan Herken, Anders Rane, Atilla Bozkurt, Mesut Çetin · 2011 · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology
  77. Interaction between a CSK Gene Variant and Fish Oil Intake Influences Blood Pressure in Healthy Adults
    Aseel Fuad Fahad AlSaleh, Zoitsa Maniou, Fiona J. Lewis, Wendy Louise Hall, T. A. B. Sanders, Sandra D. O’Dell · 2014 · Journal of Nutrition
  78. Caffeine Compromises Proliferation of Human Hippocampal Progenitor Cells
    Vikki Houghton, Andrea Du Preez, Sophie Lefèvre‐Arbogast, Chiara de Lucia, Dorrain Yanwen Low, Mireia Urpí-Sardà, Silvie R. Ruigrok, Barbara Altendorfer, Raúl González‐Domínguez, Cristina Andrés‐Lacueva et al. · 2020 · Frontiers in Cell and Developmental Biology
  79. CYP1A2 Genotype Modifies the Effects of Caffeine Compared With Placebo on Muscle Strength in Competitive Male Athletes
    Oriana Wong, Keiko Marshall, Marc Sicova, Nanci S. Guest, Bibiana García‐Bailo, Ahmed El‐Sohemy · 2021 · International Journal of Sport Nutrition and Exercise Metabolism
  80. CYP1A2 expression rather than genotype is associated with olanzapine concentration in psychiatric patients
    Ferenc Fekete, Ádám Menus, Katalin Tóth, Ádám Kiss, Annamária Minus, Dávid Sirok, Aleš Belič, Ádám Póti, Gábor Csukly, Katalin Monostory · 2023 · Scientific Reports
  81. Association between Common CYP 1 A 2Polymorphisms and Theophylline Metabolism in Non‐smoking Healthy Volunteers
    Liqing Wang, Zheyi Hu, Xun Deng, Yong Wang, Zhongyi Zhang, Zeneng Cheng · 2012 · Basic & Clinical Pharmacology & Toxicology
  82. Frequency of –163 C > A and 63 C > G single nucleotide polymorphism of cytochrome P450 1A2 in two African populations
    Collet Dandara, Patience T. Basvi, Tashinga E. Bapiro, Jane Sayi, Julia A. Hasler · 2004 · Clinical Chemistry and Laboratory Medicine (CCLM)
  83. Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians
    Fabiana B. Kohlrausch, Ángel Carracedo, Mara Helena Hutz · 2014 · Molecular Biology Reports
  84. Biomonitoring of complex occupational exposures to carcinogens: The case of sewage workers in Paris
    Hamzeh Al Zabadi, Luc Ferrari, Anne-Marie Laurent, Aziz Tiberguent, Christophe Paris, Denis Zmirou‐Navier · 2008 · BMC Cancer
  85. Influence of a CYP1A2 polymorphism on post-exercise heart rate variability in response to caffeine intake: a double-blind, placebo-controlled trial
    Thomas, R. M., Algrain, H. A., Ryan, E. J., Popojas, A., Carrigan, P., Abdulrahman, A., Carrillo, A. E. · 2017 · Irish Journal of Medical Science (1971 -)
  86. The complexity of coffee and its impact on metabolism
    Huanan Zhang, John Roger Speakman · 2024 · Journal of Endocrinology
  87. CYP1A2 164 A-->C polymorphism, cigarette smoking, consumption of well-done red meat and risk of developing colorectal adenomas and carcinomas.
    Mona Sæbø, Camilla Furu Skjelbred, Karin Brekke Li, Inger Marie Bowitz Lothe, Per Chr. Hagen, Egil Johnsen, Kjell M. Tveit, Elin Hegland Kure · 2008 · PubMed
  88. Polymorphisms of Cytochrome P450 1A2 and N-acetyltransferase Genes, Meat Consumption, and Risk of Colorectal Cancer
    Chih‐Ching Yeh, Fung‐Chang Sung, Reiping Tang, Chung Rong Chang-Chieh, Ling‐Ling Hsieh · 2009 · Diseases of the Colon & Rectum
  89. Pleiotropic Functions of Cytochrome P450 Monooxygenase-Derived Eicosanoids in Cancer
    Ying Luo, Jun‐Yan Liu · 2020 · Frontiers in Pharmacology
  90. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects
    Li‐Xin Qiu, Lei Yao, Chen Mao, Ke‐Da Yu, Ping Zhan, Bo Chen, Hui Yuan, Jian Zhang, Kai Xue, Xichun Hu · 2010 · Breast Cancer Research and Treatment
  91. Caffeine, CYP1A2 genotype, and sports performance: is timing important?
    Craig Pickering · 2018 · Irish Journal of Medical Science (1971 -)
  92. Development of analytical technology in pharmacogenetic research
    Ann K. Daly · 2004 · Naunyn-Schmiedeberg s Archives of Pharmacology
  93. Moving towards Specific Nutrigenetic Recommendation Algorithms: Caffeine, Genetic Variation and Cardiovascular Risk
    Raffaele De Caterina, Ahmed El‐Sohemy · 2016 · Lifestyle Genomics
  94. Verapamil: new insight into the molecular mechanism of drug oxidation in the human heart
    Markus Walles, Thomas Thum, Karsten Levsen, Jürgen T. Borlak · 2002 · Journal of Chromatography A
  95. Delineating gene–environment effects using virtual twins of patients treated with clozapine
    Sam Mostafa, Thomas M. Polasek, Chad Bousman, Amin Rostami‐Hodjegan, Leslie J. Sheffield, Ian Everall, Christos Pantelis, Carl M. J. Kirkpatrick · 2022 · CPT Pharmacometrics & Systems Pharmacology
  96. Does ergogenic effect of caffeine supplementation depend on CYP1A2 genotypes? A systematic review with meta-analysis
    Jieping Wang, Luthfia Dewi, Yundong Peng, Chien‐Wen Hou, Yanmin Song, Giancarlo Condello · 2023 · Journal of sport and health science/Journal of Sport and Health Science
  97. Influence of genetic polymorphisms and habitual caffeine intake on the changes in blood pressure, pulse rate, and calculation speed after caffeine intake: A prospective, double blind, randomized trial in healthy volunteers
    Tatsuya Yoshihara, Masayoshi Zaitsu, Fumie Shiraishi, Hisatomi Arima, Fumi Takahashi‐Yanaga, Masaki Arioka, Shunichi Kajioka, Toshiyuki Sasaguri · 2019 · Journal of Pharmacological Sciences
  98. Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritis
    Ashley Mark Hopkins, Michael David Wiese, Susanna Proudman, Catherine O’Doherty, Richard Neil Upton, David J. R. Foster · 2015 · British Journal of Clinical Pharmacology
  99. Cytochrome P4501A2 phenotype and bladder cancer risk: The Shanghai bladder cancer study
    Tao Li, Yong‐Bing Xiang, Kenneth K. Chan, Renwei Wang, Yu‐Tang Gao, Mimi C. Yu, Jian‐Min Yuan · 2011 · International Journal of Cancer
  100. Genotype-guided dietary supplementation in precision nutrition
    Kalliopi K. Gkouskou, Maria G. Grammatikopoulou, Ioannis Michael Vlastos, Despina Sanoudou, Aristides G. Eliopoulos · 2020 · Nutrition Reviews